Ethicon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1992-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ethicon.com
The EVICEL® Gastrointestinal Study
- First Posted Date
- 2012-05-02
- Last Posted Date
- 2015-02-25
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 214
- Registration Number
- NCT01589822
- Locations
- 🇺🇸
Clinical Investigation Site #1, Irvine, California, United States
🇺🇸Clinical Investigation Site #5, Augusta, Georgia, United States
🇺🇸Clinical Investigation Site #2, Jacksonville, Florida, United States
A Study to Evaluate the Safety and Effectiveness of EVICEL as an Adjunct to Sutured Dural Repair
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2012-06-20
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 139
- Registration Number
- NCT01174992
- Locations
- 🇳🇱
VU Medical Centre, Amsterdam, Netherlands
🇧🇪Department of Neurosurgery, Ziekenhuis Oost Limburg, Genk, Belgium
🇧🇪Department of Neurosurgery, University Hospital of Liège, Liège, Belgium
The Fibrin Pad Liver Study
- First Posted Date
- 2010-07-21
- Last Posted Date
- 2014-01-20
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 84
- Registration Number
- NCT01166243
- Locations
- 🇬🇧
Addenbrookes Hospital, Cambridge, United Kingdom
🇩🇪University Hospital of the University of Saarland, Strasse, Germany
🇳🇿Auckland City Hospital, Grafton, New Zealand
Flexible Composite Next Generation Tissue Separating Mesh in Laparoscopic Incisional/Ventral Hernia Repair
- First Posted Date
- 2010-07-14
- Last Posted Date
- 2011-04-27
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT01162564
- Locations
- 🇺🇸
Eastern Virginia Medical School, Norfolk, Virginia, United States
🇺🇸Washington University School of Medicine / Dept of Surgery, St. Louis, Missouri, United States
🇺🇸Capital Region Hospital, Jefferson City, Missouri, United States
The Evicel Post-Authorization Surveillance Study
- Conditions
- Interventions
- First Posted Date
- 2010-07-08
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT01158261
- Locations
- 🇺🇸
Memorial Hospital, Jacksonville, Florida, United States
🇺🇸Baptist Health Medical Center, Jacksonville, Florida, United States
A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device
- First Posted Date
- 2010-06-09
- Last Posted Date
- 2011-02-17
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 2
- Registration Number
- NCT01140555
- Locations
- 🇩🇪
Frauenklinik, Universitatsklinikum Erlangen, Erlangen, Germany
🇳🇴Ullevaal University Hospital, Department of Obstetrics & Gynaecology, Oslo, Norway
🇳🇱Vrije Universiteit medisch centrum (VU Medical Center), Dept of Obstetrics and Gynaecology, Amsterdam, Netherlands
A Pilot Study to Evaluate the Clinical Effectiveness and Safety of the VFIX Device as Treatment for Apical Prolapse
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01111409
- Locations
- 🇦🇺
QEII Hospital, Brisbane, Australia
🇦🇺Frances Perry House, Parkville, Australia
🇦🇺Urogynaecology Unit, Royal Women's Hospital, Parkville, Australia
A Prospective Study of the NUVANCE Facial Rejuvenation System for Mid-Face, Neck and Jowl Rejuvenation Procedures
- Conditions
- Interventions
- First Posted Date
- 2010-04-08
- Last Posted Date
- 2017-08-11
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01100190
- Locations
- 🇫🇷
Bernard Mole, Paris, France
🇩🇪Martin-Luther-Krankenhaus, Berlin, Germany
🇫🇷Catherine Bergeret-Galley, Paris, France
The Severe Soft Tissue Bleeding Study
- Conditions
- Interventions
- First Posted Date
- 2009-09-16
- Last Posted Date
- 2015-10-01
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT00977925
- Locations
- 🇦🇺
Flinders Medical Centre, Bedford Park, Australia
🇦🇺Bankstown Hospital, Bankstown, Australia
🇦🇺The Townsville Hospital, Douglas, Australia
A Surgical Simulation Study to Evaluate the Safety of a Device Mechanism as Treatment for Vaginal Apical Prolapse
- Conditions
- First Posted Date
- 2009-08-26
- Last Posted Date
- 2010-02-10
- Lead Sponsor
- Ethicon, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT00965952
- Locations
- 🇦🇺
Royal Women's Hospital, Melbourne, Victoria, Australia
🇦🇺North Shore Private Hospital, Sydney, New South Wales, Australia
🇦🇺St George Private Hospital, Sydney, New South Wales, Australia